TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY

Canadian banks or Manulife (MFC-T)? Until recently, he thought lifecos showed relatively better valuation than banks. The environment has got to the point now where flight to safety might be tilting a little bit more towards banks. Management has done a superb job since they were in trouble previously and had to cut their dividend. Have changed their product mix so that it is a lot less risky and less exposed to equity markets. Have really built up the wealth side of their business giving them good fees. Expanded in the US through John Hancock and are expanding into Asia quite a bit. A very good long-term hold.

PAST TOP PICK

(A Top Pick Nov 4/14. Up 5.2%.) This has to decouple from the interest rate outlook to the value proposition. He thinks there is still upside on the stock. From a pure Book Value, pure Coverage Ratio and pure Earnings Power with its exposure to Asia, it still looks interesting to him.

BUY

The lower oil prices hurt some of the holdings. Business in Europe is picking up. Once you have had your fill with bank stocks, take a look at this one.

COMMENT

Just sold his holdings and switched into Sun Life (SLF-T). Both are very fine companies. Sun Life has a little bit higher yield, but trades at a little higher multiple. Both companies will benefit from an eventual increase in rates.

COMMENT

All lifecos will benefit in a rising interest rate environment. Recent earnings reported were not that fantastic and thinks this has to do with the historic volatility of their earnings. Doesn’t think the market is giving the lifecos the benefit of the doubt, but there is no question that this is a good way to play a rising rate environment.

BUY

Stock vs. Stock. MFC-T vs. SLF-T. MFC-T has 10% earnings growth for the next couple of years and SLF-T is a little less than that. Times like this are a buying opportunity.

COMMENT

Metrlife (MET-N) or Manulife (MFC-T). Which has a better upside? All things being equal, and if she liked both of them equally, she would prefer the Canadian stock because of the currency. They have good business in Asia which, longer-term, is going to be a good growth area. Lower interest rates are going to be a headwind, but that is a non-core issue. Valuation is not onerous and it provides an attractive yield.

COMMENT

It is going to be hard for all of the insurance companies to break out of this rut in the current conditions. (See comments under Prudential (PRU-N).)

COMMENT

If interest rates rise, this will work. If they don’t, it will stay in the same range. Excellent company. The company has been de-risked to such an extent that the increase in equities hasn’t really driven the company to a higher level. Because of this, he prefers Sun Life (SLF-T). If you have a longer-term outlook, this is fine.

COMMENT

Given where interest rates are, it is getting more and more difficult for these insurance companies to deliver on products that promise to payout a high rate for decades.

HOLD

The stock had a really good run over the last couple of years. They are very levered to higher interest rates. The story got a little ahead of itself. A better growth profile than the banks. He has no trouble holding it.

TOP PICK

Expects that in the next 12-24 months we are going to have higher yields, which will be a tailwind for this company. 45% of earnings is coming from the US. Trading below its five-year average. Solid top and bottom-line trends in Asia. Yield of 3.05%.

DON'T BUY

He has an issue with the low interest rate environment and insurance companies. But they have brought their leverage down and that has helped them. They would like to do acquisitions, but the big ones are few and far between. They can grow their ROE, but you need to still see less leverage on their balance sheet. He prefers SLF-T where they have the asset management business.

COMMENT

Manulife (MFC-T) or Sun Life (SLF-T)? Both of these companies pay decent dividends in the 3%-4% range, but the business doesn’t seem to grow very much. They don’t do very well in a low interest rate environment. He would rather do something else with his money. Not his kind of investment.

COMMENT

This is under a lot of pressure. The interest rate scenario is obviously not positive for insurance companies. The CEO wants to get the company up to $4 billion in core revenue, and right now they are at about $3 billion. They are going to need a lot of things to go right in order to get the last billion dollars squeezed out. He is right on the edge about being nervous in owning this name. 50% of their revenues are coming in from abroad including the US and Asia. They need a better market and they need rates to go up for them to do much better from here.

Showing 916 to 930 of 2,283 entries